Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposureKarina E Guziewicz, Artur V Cideciyan, William A Beltran, et al.Ophthalmology Science|October 17, 2022
Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1/2 Sepofarsen TrialArtur V Cideciyan, Samuel G Jacobson, Allen C Ho, et al.Investigative Ophthalmology & Visual Science|February 19, 2008
Retinal disease in Usher syndrome III caused by mutations in the clarin-1 geneWaldo Herrera, Tomas S Aleman, Artur V Cideciyan, et al.Human Gene Therapy|September 27, 2013
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapyArtur V Cideciyan, Robert B Hufnagel, Joseph Carroll, et al.Human Molecular Genetics|May 9, 2008
Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanismSamuel G Jacobson, Artur V Cideciyan, Tomas S Aleman, et al.Iscience|May 17, 2021
Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutationsSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosaWilliam A Beltran, Artur V Cideciyan, Alfred S Lewin, et al.Iscience|October 24, 2022
Night vision restored in days after decades of congenital blindnessSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.Investigative Ophthalmology & Visual Science|July 16, 2011
Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse modelTomas S Aleman, Artur V Cideciyan, Geoffrey K Aguirre, et al.International Journal of Molecular Sciences|October 16, 2024
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene TherapyArtur V Cideciyan, Alejandro J Roman, Raymond L Warner, et al.Pageof 11